This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fox, M. W. Articles by Meyer, F. B. Search for Related Content PubMed PubMed Citation Articles by Fox, M. W. Articles by Meyer, F. B. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

Stroke, Vol 24, 1072-1075, Copyright © 1993 by American Heart Association

ARTICLES

Neuroprotection by corticotropin releasing factor during hypoxia in rat brain

MW Fox, RE Anderson and FB Meyer
Department of Neurosurgery, Mayo Clinic, Rochester, MN 55905.

BACKGROUND AND PURPOSE: Corticotropin releasing factor is an endogenous neuropeptide released by the hypothalamus that activates the pituitary- adrenocortical system in response to stressful stimuli. It has been demonstrated that corticotropin releasing factor increases the excitability of hippocampal neurons in both in vitro and in vivo studies, which may contribute to neurological injury during hypoxia. The purpose of this study was to determine the effects of corticotropin releasing factor and its synthetic competitive antagonist, alpha-CRF, on neuronal synaptic recovery after a hypoxic insult using the hippocampal slice. METHODS: Wistar rat hippocampal brain slices (n = 120) were treated with various concentrations (10(-6) to 10(-11)) of corticotropin releasing factor or its synthetic antagonist during a 10- minute hypoxic episode. Extracellular recording of population spikes was used during and after the hypoxic insult to assess neuronal recovery. RESULTS: Corticotropin releasing factor provided dose- dependent neuronal protection with maximum recovery (37.95 +/- 8.71%) occurring at 10(-9) concentrations. The competitive antagonist alpha- CRF provided a similar degree of recovery at 10(-6) concentration, whereas 10(-9) molar concentration of competitive antagonist resulted in 16.84 +/- 7.68% recovery. CONCLUSIONS: Corticotropin releasing factor provides moderate protection to hypoxic hippocampal neurons in the brain slice preparation. The mechanism of action is unknown but appears to be a direct neuronal effect. These results support the hypothesis that corticotropin releasing factor may act as an endogenous neuroprotective hormone during hypoxia.

This article has been cited by other articles:

				R. Hanstein, J. Trotter, C. Behl, and A. B. Clement Increased Connexin 43 Expression as a Potential Mediator of the Neuroprotective Activity of the Corticotropin-Releasing Hormone Mol. Endocrinol., September 1, 2009; 23(9): 1479 - 1493. [Abstract] [Full Text] [PDF]

				J. Xu, F. Xu, J. D. Hennebold, T. A. Molskness, and R. L. Stouffer Expression and Role of the Corticotropin-Releasing Hormone/Urocortin-Receptor-Binding Protein System in the Primate Corpus Luteum during the Menstrual Cycle Endocrinology, November 1, 2007; 148(11): 5385 - 5395. [Abstract] [Full Text] [PDF]

				G. C. Boorse, C. A. Kholdani, A. F. Seasholtz, and R. J. Denver Corticotropin-Releasing Factor Is Cytoprotective in Xenopus Tadpole Tail: Coordination of Ligand, Receptor, and Binding Protein in Tail Muscle Cell Survival Endocrinology, March 1, 2006; 147(3): 1498 - 1507. [Abstract] [Full Text] [PDF]

				G. Graziani, L. Tentori, I. Portarena, M. Barbarino, G. Tringali, G. Pozzoli, and P. Navarra CRH Inhibits Cell Growth of Human Endometrial Adenocarcinoma Cells via CRH-Receptor 1-Mediated Activation of cAMP-PKA Pathway Endocrinology, March 1, 2002; 143(3): 807 - 813. [Abstract] [Full Text] [PDF]

				B. K. Brar, A. K. Jonassen, A. Stephanou, G. Santilli, J. Railson, R. A. Knight, D. M. Yellon, and D. S. Latchman Urocortin Protects against Ischemic and Reperfusion Injury via a MAPK-dependent Pathway J. Biol. Chem., March 17, 2000; 275(12): 8508 - 8514. [Abstract] [Full Text] [PDF]

				F. Lezoualc’h, S. Engert, B. Berning, and C. Behl Corticotropin-Releasing Hormone-Mediated Neuroprotection against Oxidative Stress Is Associated with the Increased Release of Non-amyloidogenic Amyloid {beta} Precursor Protein and with the Suppression of Nuclear Factor-{kappa}B Mol. Endocrinol., January 1, 2000; 14(1): 147 - 159. [Abstract] [Full Text]